Literature DB >> 24569509

Abandon the mouse research ship? Not just yet!

Marcin F Osuchowski1, Daniel G Remick, James A Lederer, Charles H Lang, Ansgar O Aasen, Mayuki Aibiki, Luciano C Azevedo, Soheyl Bahrami, Mihaly Boros, Robert Cooney, Salvatore Cuzzocrea, Yong Jiang, Wolfgang G Junger, Hiroyuki Hirasawa, Richard S Hotchkiss, Xiang-An Li, Peter Radermacher, Heinz Redl, Reinaldo Salomao, Amin Soebandrio, Christoph Thiemermann, Jean-Louis Vincent, Peter Ward, Yong-Ming Yao, Huang-Ping Yu, Basilia Zingarelli, Irshad H Chaudry.   

Abstract

Many preclinical studies in critical care medicine and related disciplines rely on hypothesis-driven research in mice. The underlying premise posits that mice sufficiently emulate numerous pathophysiologic alterations produced by trauma/sepsis and can serve as an experimental platform for answering clinically relevant questions. Recently, the lay press severely criticized the translational relevance of mouse models in critical care medicine. A series of provocative editorials were elicited by a highly publicized research report in the Proceedings of the National Academy of Sciences (PNAS; February 2013), which identified an unrecognized gene expression profile mismatch between human and murine leukocytes following burn/trauma/endotoxemia. Based on their data, the authors concluded that mouse models of trauma/inflammation are unsuitable for studying corresponding human conditions. We believe this conclusion was not justified. In conjunction with resulting negative commentary in the popular press, it can seriously jeopardize future basic research in critical care medicine. We will address some limitations of that PNAS report to provide a framework for discussing its conclusions and attempt to present a balanced summary of strengths/weaknesses of use of mouse models. While many investigators agree that animal research is a central component for improved patient outcomes, it is important to acknowledge known limitations in clinical translation from mouse to man. The scientific community is responsible to discuss valid limitations without overinterpretation. Hopefully, a balanced view of the strengths/weaknesses of using animals for trauma/endotoxemia/critical care research will not result in hasty discount of the clear need for using animals to advance treatment of critically ill patients.

Entities:  

Mesh:

Year:  2014        PMID: 24569509      PMCID: PMC4139038          DOI: 10.1097/SHK.0000000000000153

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.533


  185 in total

1.  Gene-specific control of inflammation by TLR-induced chromatin modifications.

Authors:  Simmie L Foster; Diana C Hargreaves; Ruslan Medzhitov
Journal:  Nature       Date:  2007-05-30       Impact factor: 49.962

2.  A comparison of selected mRNA and protein abundances in human liver.

Authors:  L Anderson; J Seilhamer
Journal:  Electrophoresis       Date:  1997 Mar-Apr       Impact factor: 3.535

3.  Mixed antagonist response and sepsis severity-dependent dysbalance of pro- and anti-inflammatory responses at the onset of postoperative sepsis.

Authors:  Alexander R Novotny; Daniel Reim; Volker Assfalg; Felicitas Altmayr; Helmut M Friess; Klaus Emmanuel; Bernhard Holzmann
Journal:  Immunobiology       Date:  2011-11-03       Impact factor: 3.144

4.  Blockade of tumor necrosis factor reduces lipopolysaccharide lethality, but not the lethality of cecal ligation and puncture.

Authors:  D Remick; P Manohar; G Bolgos; J Rodriguez; L Moldawer; G Wollenberg
Journal:  Shock       Date:  1995-08       Impact factor: 3.454

Review 5.  Immunodepression in sepsis and SIRS assessed by ex vivo cytokine production is not a generalized phenomenon: a review.

Authors:  J M Cavaillon; M Adib-Conquy; I Cloëz-Tayarani; C Fitting
Journal:  J Endotoxin Res       Date:  2001

6.  Look back in anger - what clinical studies tell us about preclinical work.

Authors:  Thomas Hartung
Journal:  ALTEX       Date:  2013       Impact factor: 6.043

7.  Relationship of plasma gelsolin levels to outcomes in critically ill surgical patients.

Authors:  Po-Shun Lee; Leslie R Drager; Thomas P Stossel; Francis D Moore; Selwyn O Rogers
Journal:  Ann Surg       Date:  2006-03       Impact factor: 12.969

8.  Temporal cytokine profiles in severely burned patients: a comparison of adults and children.

Authors:  Celeste C Finnerty; Marc G Jeschke; David N Herndon; Richard Gamelli; Nicole Gibran; Matthew Klein; Geoff Silver; Brett Arnoldo; Daniel Remick; Ronald G Tompkins
Journal:  Mol Med       Date:  2008 Sep-Oct       Impact factor: 6.354

9.  Anti-tumor necrosis factor antibody therapy fails to prevent lethality after cecal ligation and puncture or endotoxemia.

Authors:  M K Eskandari; G Bolgos; C Miller; D T Nguyen; L E DeForge; D G Remick
Journal:  J Immunol       Date:  1992-05-01       Impact factor: 5.422

10.  Increased plasma levels of interleukin-6 in sepsis.

Authors:  C E Hack; E R De Groot; R J Felt-Bersma; J H Nuijens; R J Strack Van Schijndel; A J Eerenberg-Belmer; L G Thijs; L A Aarden
Journal:  Blood       Date:  1989-10       Impact factor: 22.113

View more
  82 in total

1.  The in Vitro Immune-Modulating Properties of a Sweat Gland-Derived Antimicrobial Peptide Dermcidin.

Authors:  Echo Wang; Xiaoling Qiang; Jianhua Li; Shu Zhu; Ping Wang
Journal:  Shock       Date:  2016-01       Impact factor: 3.454

2.  Peritoneal wash contents used to predict mortality in a murine sepsis model.

Authors:  Joshua W Kuethe; Emily F Midura; Teresa C Rice; Charles C Caldwell
Journal:  J Surg Res       Date:  2015-04-25       Impact factor: 2.192

Review 3.  The future of murine sepsis and trauma research models.

Authors:  Philip A Efron; Alicia M Mohr; Frederick A Moore; Lyle L Moldawer
Journal:  J Leukoc Biol       Date:  2015-06-01       Impact factor: 4.962

4.  Lymph node fibroblastic reticular cell transplants show robust therapeutic efficacy in high-mortality murine sepsis.

Authors:  Anne L Fletcher; Jessica S Elman; Jillian Astarita; Ryan Murray; Nima Saeidi; Joshua D'Rozario; Konstantin Knoblich; Flavian D Brown; Frank A Schildberg; Janice M Nieves; Tracy S P Heng; Richard L Boyd; Shannon J Turley; Biju Parekkadan
Journal:  Sci Transl Med       Date:  2014-08-13       Impact factor: 17.956

Review 5.  Current Murine Models of Sepsis.

Authors:  Anthony J Lewis; Christopher W Seymour; Matthew R Rosengart
Journal:  Surg Infect (Larchmt)       Date:  2016-06-15       Impact factor: 2.150

6.  Use of a Central Venous Line for Fluids, Drugs and Nutrient Administration in a Mouse Model of Critical Illness.

Authors:  Sarah Derde; Steven Thiessen; Chloë Goossens; Thomas Dufour; Greet Van den Berghe; Lies Langouche
Journal:  J Vis Exp       Date:  2017-05-02       Impact factor: 1.355

Review 7.  Bench-to-Bedside: A Translational Perspective on Murine Models of Sepsis.

Authors:  Anthony J Lewis; Matthew R Rosengart
Journal:  Surg Infect (Larchmt)       Date:  2018-02-02       Impact factor: 2.150

8.  Mice engrafted with human hematopoietic stem cells support a human myeloid cell inflammatory response in vivo.

Authors:  Andrew Baird; Chenliang Deng; Matthew H Eliceiri; Fatima Haghi; Xitong Dang; Raul Coimbra; Todd W Costantini; Bruce E Torbett; Brian P Eliceiri
Journal:  Wound Repair Regen       Date:  2016-10-04       Impact factor: 3.617

9.  Intestine-Derived Matrix Metalloproteinase-8 Is a Critical Mediator of Polymicrobial Peritonitis.

Authors:  Sarah J Atkinson; Meghan Nolan; Lindsey Klingbeil; Kelli Harmon; Patrick Lahni; Basilia Zingarelli; Hector R Wong
Journal:  Crit Care Med       Date:  2016-04       Impact factor: 7.598

Review 10.  Consequences of extracellular trap formation in sepsis.

Authors:  Xian M O'Brien; Bethany M Biron; Jonathan S Reichner
Journal:  Curr Opin Hematol       Date:  2017-01       Impact factor: 3.284

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.